Literature DB >> 19661989

Genetics and neuropsychiatric disorders: treatment during adulthood.

Dan Ehninger1, Alcino J Silva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19661989     DOI： 10.1038/nm0809-849

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.

Authors:  Weidong Li; Yijun Cui; Steven A Kushner; Robert A M Brown; J David Jentsch; Paul W Frankland; Tyrone D Cannon; Alcino J Silva
Journal:  Curr Biol       Date:  2005-11-08       Impact factor: 10.834

2.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

Authors:  Q J Yan; M Rammal; M Tranfaglia; R P Bauchwitz
Journal:  Neuropharmacology       Date:  2005-07-27       Impact factor: 5.250

3.  Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.

Authors:  Dan Ehninger; Sangyeul Han; Carrie Shilyansky; Yu Zhou; Weidong Li; David J Kwiatkowski; Vijaya Ramesh; Alcino J Silva
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

4.  Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; Allison Sumis; Crystal Hervey; Michael Nelson; Stephen W Porges; Ning Weng; Ivan Jeanne Weiler; William T Greenough
Journal:  J Dev Behav Pediatr       Date:  2008-08       Impact factor: 2.225

5.  Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.

Authors:  Femke M S de Vrij; Josien Levenga; Herma C van der Linde; Sebastiaan K Koekkoek; Chris I De Zeeuw; David L Nelson; Ben A Oostra; Rob Willemsen
Journal:  Neurobiol Dis       Date:  2008-04-25       Impact factor: 5.996

6.  Correction of fragile X syndrome in mice.

Authors:  Gül Dölen; Emily Osterweil; B S Shankaranarayana Rao; Gordon B Smith; Benjamin D Auerbach; Sumantra Chattarji; Mark F Bear
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

7.  Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.

Authors:  Lianne C Krab; Arja de Goede-Bolder; Femke K Aarsen; Saskia M F Pluijm; Marlies J Bouman; Jos N van der Geest; Maarten Lequin; Coriene E Catsman; Willem Frans M Arts; Steven A Kushner; Alcino J Silva; Chris I de Zeeuw; Henriëtte A Moll; Ype Elgersma
Journal:  JAMA       Date:  2008-07-16       Impact factor: 56.272

Review 8.  The mGluR theory of fragile X mental retardation.

Authors:  Mark F Bear; Kimberly M Huber; Stephen T Warren
Journal:  Trends Neurosci       Date:  2004-07       Impact factor: 13.837

9.  Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory.

Authors:  François V Bolduc; Kimberly Bell; Hilary Cox; Kendal S Broadie; Tim Tully
Journal:  Nat Neurosci       Date:  2008-09-07       Impact factor: 24.884

10.  A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.

Authors:  E Berry-Kravis; D Hessl; S Coffey; C Hervey; A Schneider; J Yuhas; J Hutchison; M Snape; M Tranfaglia; D V Nguyen; R Hagerman
Journal:  J Med Genet       Date:  2009-01-06       Impact factor: 6.318
View more
  14 in total

1.  Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice.

Authors:  D Ehninger; Y Sano; P J de Vries; K Dies; D Franz; D H Geschwind; M Kaur; Y-S Lee; W Li; J K Lowe; J A Nakagawa; M Sahin; K Smith; V Whittemore; A J Silva
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 2.  Autism spectrum disorder: advances in evidence-based practice.

Authors:  Evdokia Anagnostou; Lonnie Zwaigenbaum; Peter Szatmari; Eric Fombonne; Bridget A Fernandez; Marc Woodbury-Smith; Jessica Brian; Susan Bryson; Isabel M Smith; Irene Drmic; Janet A Buchanan; Wendy Roberts; Stephen W Scherer
Journal:  CMAJ       Date:  2014-01-13       Impact factor: 8.262

Review 3.  Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.

Authors:  Hala Harony-Nicolas; Silvia De Rubeis; Alexander Kolevzon; Joseph D Buxbaum
Journal:  J Child Neurol       Date:  2015-09-08       Impact factor: 1.987

Review 4.  Multiple cellular cascades participate in long-term potentiation and in hippocampus-dependent learning.

Authors:  Michel Baudry; Guoqi Zhu; Yan Liu; Yubin Wang; Victor Briz; Xiaoning Bi
Journal:  Brain Res       Date:  2014-12-04       Impact factor: 3.252

5.  Automated assessment of pavlovian conditioned freezing and shock reactivity in mice using the video freeze system.

Authors:  Stephan G Anagnostaras; Suzanne C Wood; Tristan Shuman; Denise J Cai; Arthur D Leduc; Karl R Zurn; J Brooks Zurn; Jennifer R Sage; Gerald M Herrera
Journal:  Front Behav Neurosci       Date:  2010-09-30       Impact factor: 3.558

Review 6.  Potential pharmacological treatment of fragile X syndrome during adulthood.

Authors:  Zhao-Hui Xu; Ming-Gao Zhao
Journal:  Neurosci Bull       Date:  2009-10       Impact factor: 5.203

7.  Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.

Authors:  Agnies M van Eeghen; Margaret B Pulsifer; Vanessa L Merker; Ann M Neumeyer; Elmer E van Eeghen; Ronald L Thibert; Andrew J Cole; Fawn A Leigh; Scott R Plotkin; Elizabeth A Thiele
Journal:  Dev Med Child Neurol       Date:  2012-12-04       Impact factor: 5.449

8.  Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication.

Authors:  Ozlem Bozdagi; Takeshi Sakurai; Danae Papapetrou; Xiaobin Wang; Dara L Dickstein; Nagahide Takahashi; Yuji Kajiwara; Mu Yang; Adam M Katz; Maria Luisa Scattoni; Mark J Harris; Roheeni Saxena; Jill L Silverman; Jacqueline N Crawley; Qiang Zhou; Patrick R Hof; Joseph D Buxbaum
Journal:  Mol Autism       Date:  2010-12-17       Impact factor: 7.509

9.  Networks of neuronal genes affected by common and rare variants in autism spectrum disorders.

Authors:  Eyal Ben-David; Sagiv Shifman
Journal:  PLoS Genet       Date:  2012-03-08       Impact factor: 5.917

10.  CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation.

Authors:  Silvia De Rubeis; Emanuela Pasciuto; Ka Wan Li; Esperanza Fernández; Daniele Di Marino; Andrea Buzzi; Linnaea E Ostroff; Eric Klann; Fried J T Zwartkruis; Noboru H Komiyama; Seth G N Grant; Christel Poujol; Daniel Choquet; Tilmann Achsel; Danielle Posthuma; August B Smit; Claudia Bagni
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.